TABLE 3.
Comparison of the dosimetric parameters for nasopharyngeal tumor cases with RBE = 1.1 (equal to the treatment plan) and the variable RBE.
| Case | Tissue | Dosimetric parameter | PTV‐based opt. (cGy [RBE]) | Robust opt. (cGy [RBE]) | ||||
|---|---|---|---|---|---|---|---|---|
| RBE = 1.1 | Variable RBE | [%] | RBE = 1.1 | Variable RBE | [%] | |||
| CaseA | CTV | D 99 | 7220 | 7534/6987 | 4.4/−3.3 | 7223 | 7510/6980 | 4.0/−3.4 |
| D 98,worst | – | – | 7040 | – | ||||
| PTV | D 95 | 7236 | – | – | – | |||
| Brainstem | D max | 3893 | 4947 | 15.2 | 4029 | 4675 | 9.0 | |
| Spinal cord | D max | 4199 | 5593 | 19.5 | 4199 | 4947 | 10.5 | |
| CaseB | CTV | D 99 | 7215 | 7531/6994 | 4.4/−3.1 | 7211 | 7585/7052 | 5.2/−2.2 |
| D 98,worst | – | – | 7042 | – | ||||
| PTV | D 95 | 7232 | – | – | – | |||
| Brainstem | D max | 4505 | 5967 | 20.5 | 4573 | 5355 | 11.4 | |
| Spinal cord | D max | 2907 | 3893 | 13.8 | 2805 | 3417 | 8.6 | |
| CaseC | CTV | D 99 | 7198 | 7504/6960 | 4.3/−3.3 | 7221 | 7589/7028 | 5.2/−2.7 |
| D 98,worst | – | – | 7039 | ‐ | ||||
| PTV | D 95 | 7215 | – | – | – | |||
| Brainstem | D max | 4845 | 6001 | 16.2 | 4845 | 5797 | 13.3 | |
| Spinal cord | D max | 3553 | 4743 | 16.7 | 3281 | 4233 | 13.3 | |
| CaseD | CTV | D 99 | 7225 | 7531/7055 | 4.3/−2.4 | 7225 | 7463/6953 | 3.3/−3.8 |
| D 98,worst | – | – | 7157 | – | ||||
| PTV | D 95 | 7191 | – | 16.7 | – | – | 13.3 | |
| Brainstem | D max | 3859 | 5015 | 16.2 | 3689 | 4675 | 13.8 | |
| Spinal cord | D max | 3077 | 4199 | 15.7 | 3043 | 3995 | 13.3 | |
As for the dosimetric parameters for the CTV calculated with the variable RBE, the results of and are shown in the left and right sides in the same cell, respectively. Values of the dosimetric parameters are rounded to the nearest 0.1 cGy.
CTV, clinical target volume; PTV, planning target volume; RBE, relative biological effectiveness.